UBS Group’s Minerva Neurosciences NERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.51K Sell
875
-746
-46% -$1.28K ﹤0.01% 8283
2025
Q1
$2.76K Buy
1,621
+1,609
+13,408% +$2.74K ﹤0.01% 7968
2024
Q4
$27 Sell
12
-10,540
-100% -$23.7K ﹤0.01% 8507
2024
Q3
$28.2K Buy
10,552
+10,542
+105,420% +$28.1K ﹤0.01% 5952
2024
Q2
$32 Hold
10
﹤0.01% 8104
2024
Q1
$26 Sell
10
-55
-85% -$143 ﹤0.01% 7833
2023
Q4
$400 Buy
65
+12
+23% +$74 ﹤0.01% 7467
2023
Q3
$366 Sell
53
-381
-88% -$2.63K ﹤0.01% 7399
2023
Q2
$3.97K Buy
+434
New +$3.97K ﹤0.01% 6502
2022
Q4
Sell
-5,732
Closed -$53K 9707
2022
Q3
$53K Buy
5,732
+5,167
+915% +$47.8K ﹤0.01% 5234
2022
Q2
$2K Buy
565
+563
+28,150% +$1.99K ﹤0.01% 8546
2022
Q1
$0 Hold
2
﹤0.01% 9451
2021
Q4
$0 Hold
2
﹤0.01% 9296
2021
Q3
$0 Sell
2
-1,164
-100% ﹤0.01% 8627
2021
Q2
$22K Sell
1,166
-2,086
-64% -$39.4K ﹤0.01% 6147
2021
Q1
$76K Buy
3,252
+328
+11% +$7.67K ﹤0.01% 5178
2020
Q4
$55K Buy
2,924
+2,809
+2,443% +$52.8K ﹤0.01% 5108
2020
Q3
$3K Sell
115
-1,089
-90% -$28.4K ﹤0.01% 6661
2020
Q2
$35K Sell
1,204
-4,258
-78% -$124K ﹤0.01% 5326
2020
Q1
$263K Buy
5,462
+814
+18% +$39.2K ﹤0.01% 3692
2019
Q4
$265K Buy
4,648
+2,526
+119% +$144K ﹤0.01% 4407
2019
Q3
$132K Buy
+2,122
New +$132K ﹤0.01% 4672
2019
Q1
Sell
-127
Closed -$7K 7017
2018
Q4
$7K Sell
127
-27
-18% -$1.49K ﹤0.01% 6489
2018
Q3
$15K Sell
154
-380
-71% -$37K ﹤0.01% 6049
2018
Q2
$35K Buy
534
+418
+360% +$27.4K ﹤0.01% 5372
2018
Q1
$6K Buy
+116
New +$6K ﹤0.01% 6263
2017
Q4
Sell
-785
Closed -$48K 6927
2017
Q3
$48K Buy
785
+727
+1,253% +$44.5K ﹤0.01% 4937
2017
Q2
$4K Buy
58
+28
+93% +$1.93K ﹤0.01% 6256
2017
Q1
$2K Sell
30
-233
-89% -$15.5K ﹤0.01% 6359
2016
Q4
$25K Buy
263
+8
+3% +$760 ﹤0.01% 5439
2016
Q3
$29K Buy
+255
New +$29K ﹤0.01% 5090
2016
Q2
Sell
-5,894
Closed -$290K 6873
2016
Q1
$290K Buy
5,894
+5,658
+2,397% +$278K ﹤0.01% 3519
2015
Q4
$11K Buy
236
+143
+154% +$6.67K ﹤0.01% 5953
2015
Q3
$4K Buy
+93
New +$4K ﹤0.01% 6372